{
    "clinical_study": {
        "@rank": "102322", 
        "arm_group": [
            {
                "arm_group_label": "Dark chocolate", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Placebo chocolate", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to to test the feasibility of design methods and procedures for\n      later use on a larger scale and to examine the acute and chronic effect of consumption of\n      flavanol-rich chocolate on endothelium function and blood pressure in healthy pregnant\n      women."
        }, 
        "brief_title": "Chocolate Consumption in Healthy Pregnant Women Trial", 
        "completion_date": {
            "#text": "April 2009", 
            "@type": "Actual"
        }, 
        "condition": "Hypertension Pregnancy-induced", 
        "condition_browse": {
            "mesh_term": [
                "Hypertension", 
                "Pre-Eclampsia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  non-smoking normotensive women aged from 18 to 35 years, between the 7 and 12 weeks\n             of gestation (documented by ultrasound) and having a live fetus confirmed by fetal\n             heart auscultation\n\n        Exclusion Criteria:\n\n          -  Patients with family history of premature cardiovascular disease\n\n          -  Chronic hypertension\n\n          -  Currently or previously use of medications interfering with glucose or     lipids\n             metabolism.\n\n          -  Use of supplements or natural health products that interfere with blood pressure.\n\n          -  Consumption of 1 or more alcohol drink per day.\n\n          -  Allergy or intolerance to nuts or chocolate."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "35 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "44", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 31, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01659060", 
            "org_study_id": "119.05.03"
        }, 
        "intervention": [
            {
                "arm_group_label": "Dark chocolate", 
                "description": "The primary objective of this pilot RCT is to test the feasibility of design methods and procedures for later use on a larger scale. The secondary objective is to examine the acute and chronic effect of dark chocolate on endothelial function and blood pressure, among healthy pregnant women.", 
                "intervention_name": "Flavanol-rich dark chocolate", 
                "intervention_type": "Other", 
                "other_name": "Chocolate rich in flavanols"
            }, 
            {
                "arm_group_label": "Placebo chocolate", 
                "description": "Placebo intervention", 
                "intervention_name": "Placebo Chocolate", 
                "intervention_type": "Other", 
                "other_name": "Flavanol-free chocolate"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Cacao", 
            "Chocolate", 
            "Theobromine", 
            "Flavonoids", 
            "Pregnant women", 
            "Hypertension pregnancy-induced", 
            "Pre-eclampsia", 
            "Epicatechin"
        ], 
        "lastchanged_date": "August 2, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Qu\u00e9bec", 
                    "country": "Canada", 
                    "state": "Quebec", 
                    "zip": "G1V 0A6"
                }, 
                "name": "Laval University, Department of Medicine, Institut des nutraceutiques et des aliments fonctionnels"
            }
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "Assessment of Blood Pressure and Endothelial Function Pregnancy After Acute and Daily Consumption Flavanol-rich Chocolate Among Healthy Pregnant Women: a Pilot Randomized Controlled Trial", 
        "overall_official": {
            "affiliation": "Laval University", 
            "last_name": "Sylvie Dodin, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Canada: Canadian Institutes of Health Research", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "April 2009", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Changes in endothelial function and blood pressure", 
            "safety_issue": "No", 
            "time_frame": "within the first 12 weeks of chocolate intake (week 12 and baseline)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01659060"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Changes from baseline in plasma flavanol and methylxanthines(caffeine, theobromine and theophylline) concentrations at 12 weeks", 
                "safety_issue": "No", 
                "time_frame": "within the first 12 weeks of chocolate intake (week 12 and baseline)"
            }, 
            {
                "measure": "Weight change from baseline at 12 weeks", 
                "safety_issue": "No", 
                "time_frame": "within the first 12 weeks of chocolate intake (week 12 and baseline)"
            }, 
            {
                "measure": "Number of participants with digestive and other signs and symptoms (nausea, abdominal pain, constipation, and headache)", 
                "safety_issue": "No", 
                "time_frame": "within the first 12 weeks of chocolate intake (week 12 and baseline)"
            }
        ], 
        "source": "Laval University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Laval University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2008", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "August 2012"
    }
}